We serve Chemical Name:Sorbitol CAS:50-70-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Sorbitol
CAS.NO:50-70-4
Synonyms:Sorbitol;D-Sorbitol;T2 T4 HEXADIENAL;EINECS 200-061-5;MFCD00004708;2,4-HEXADIEN-1-AL;trans,trans-hexa-2,4-dienal;trans,trans-2,4-Hexadienal;n-Hex-2,4-dienal;hexa-2,4-dienal;sorbic aldehyde;(2R,3R,4R,5S)-Hexane-1,2,3,4,5,6-hexaol;sorbaldehyde
Molecular Formula:C6H14O6
Molecular Weight:182.172
HS Code:2905440000
Physical and Chemical Properties:
Melting point:95-99ºC
Boiling point:494.9±0.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.597
PSA:121.38000
Exact Mass:182.079041
LogP:-4.67
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Sorbitol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,sorbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,n-Hex-2,4-dienal Use and application,sorbaldehyde technical grade,usp/ep/jp grade.
Related News: The new restrictions on foreign nationals begin on February 3, Prime Minister Jacinda Ardern announced in a press release Sunday. Sorbitol manufacturer Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. Sorbitol supplier The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. Sorbitol vendor Both patients were being treated in isolation units at a Manila hospital. Sorbitol factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.
